Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for depressive episodes linked to bipolar I or bipolar II disorder (bipolar depression) in 2021. Caplyta can be ...

Researchers have used everyday Fitbit data to train a machine learning algorithm to accurately predict mood episodes ...

Bright light therapy improves remission and response rates in nonseasonal depression, enhances antidepressant effectiveness, ...

Balance Treatment Center offers a program designed to meet the needs of clients struggling with issues including depression, anxiety, bipolar disorder, psychosis, PTSD, substance abuse ...

However, stopping treatment with Caplyta may cause symptoms of schizophrenia or bipolar depression to return. (These are conditions that Caplyta is approved to treat.) If you have questions about ...

is a safe and effective treatment for both manic and depressive symptoms. ECT is often used to treat severe forms of depression or mania in bipolar I disorder when medicines may not be effective ...

As such, a treatment plan for bipolar disorder prioritizes keeping the patient safe, ensuring the safety of those around them, and reducing the frequency and severity of episodes of depression and ...